Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and … Read more
Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) - Total Liabilities
Latest total liabilities as of September 2025: ₹340.59 Million INR
Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has total liabilities worth ₹340.59 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biofil Chemicals & Pharmaceuticals Limited - Total Liabilities Trend (2008–2025)
This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Biofil Chemicals & Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Public Company Management Corp
PINK:PCMC
|
USA | $480.93K |
|
Sentra Food Indonesia Tbk PT
JK:FOOD
|
Indonesia | Rp65.76 Billion |
|
AppSpotr AB
ST:APTR
|
Sweden | Skr5.53 Million |
|
Mercator Limited
NSE:MERCATOR
|
India | ₹24.65 Billion |
|
Bait Bakfar Ltd
TA:BKFR
|
Israel | ILA990.05 Million |
|
Interbud-Lublin SA
WAR:ITB
|
Poland | zł40.81 Million |
|
OHB - Dusseldorf Stock Exchang
DU:OHB
|
Germany | €951.44 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Biofil Chemicals & Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.01 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biofil Chemicals & Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
The table below shows the annual total liabilities of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹321.79 Million | +11.42% |
| 2024-03-31 | ₹288.80 Million | +104.76% |
| 2023-03-31 | ₹141.04 Million | +644.44% |
| 2022-03-31 | ₹18.95 Million | -88.93% |
| 2021-03-31 | ₹171.09 Million | -37.74% |
| 2020-03-31 | ₹274.82 Million | +160.16% |
| 2019-03-31 | ₹105.63 Million | -3.86% |
| 2018-03-31 | ₹109.87 Million | +20.16% |
| 2017-03-31 | ₹91.44 Million | -30.86% |
| 2016-03-31 | ₹132.25 Million | +147.59% |
| 2015-03-31 | ₹53.42 Million | -20.70% |
| 2014-03-31 | ₹67.36 Million | +9.87% |
| 2013-03-31 | ₹61.31 Million | -15.70% |
| 2012-03-31 | ₹72.73 Million | +97.67% |
| 2011-03-31 | ₹36.79 Million | -56.84% |
| 2010-03-31 | ₹85.25 Million | +18.42% |
| 2009-03-31 | ₹71.99 Million | -8.89% |
| 2008-03-31 | ₹79.01 Million | -- |